ActivBiotics Pharma, LLC

Quick facts

Phase 2 pipeline

• Azithromycin 1 gram · Infectious diseases
  Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.
• Rifalazil 25 milligram

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• ActivBiotics Pharma, LLC portfolio CI brief
• ActivBiotics Pharma, LLC pipeline updates RSS

Related

• Sector hub: All tracked pharma companies